Z-0271-2023 Class II Ongoing

Recalled by Kamiya Biomedical Company, LLC — Tukwila, WA

FDA device recall Z-0271-2023 was initiated by Kamiya Biomedical Company, LLC on Sep 28, 2022 and is designated Class II. Reason for recall: IgA Reagent may start showing cloudiness over time, which can affect assay performance. The recall status is ongoing. Affected quantity: 165.

Recall details

Product Type
Devices
Report Date
Nov 30, 2022
Initiation Date
Sep 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
165

Product description

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Reason for recall

IgA Reagent may start showing cloudiness over time, which can affect assay performance.

Distribution pattern

Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.

Code information

UDI-DI: 00816426020092, Lot/ Expiration Date: H180/ 2023-01-31, K181/ 2023-03-31, N182/ 2023-06-30, D283/ 2023-09-30

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0271-2023
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Kamiya Biomedical Company, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0271-2023. Report a data issue: hello@regdatalab.com.